Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: April 2019
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 11 of 11 items.
PMS-Cetirizine tablets (2019-04-26)
RecallHealth product recall | 2019-04-26
Keytruda (2019-04-23)
RecallHealth product recall | 2019-04-23
Centre for Probe Development and Commercialization Products Recall (2019-04-17)
RecallHealth product recall | 2019-04-17
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
AlertHealth professional risk communication | 2019-04-17
Auro-Irbesartan HCT Tablet (2019-04-17)
RecallHealth product recall | 2019-04-17
Ibuprofen tablets (2019-04-16)
RecallHealth product recall | 2019-04-16
Health Canada testing identifies additional health risks involving unauthorized products sold by A1 Herbal Ayurvedic Clinic Ltd.
AlertInformation update | 2019-04-12
Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)
RecallHealth product recall | 2019-04-12
PMS-Sulfasalazine product recall (2019-04-09)
RecallHealth product recall | 2019-04-09
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04